发布于: 公告转发:0回复:0喜欢:0
$Reata Pharmaceuticals, Inc. Class A Common Stock(RETA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-04-24 AccNo: 0001564590-17-006935 Size: 193 KB 网页链接